Profusa, Inc.

PFSA
$0.22 (- $0.02 - 6.78%)
Last updated: 2026-06-17 09:50 UTC
PFSA Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Devices
ISINUS74319X2071
CUSIP74319X207
Market Price0.22
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.71
Market Cap$6.9M
Book Value-0.81
Price to Book-0.098
Beta-0.2
52w High5.5
52w Low0.07
Next Earnings DateN/A

Profusa, Inc. trades under ticker PFSA on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US74319X2071, CUSIP 74319X207.

About the Company
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Price History